HMGB1, high mobility group box 1, 3146

N. diseases: 724; N. variants: 10
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0004096
Disease: Asthma
Asthma
0.100 Biomarker disease BEFREE The expression of HMGB1 could be negatively regulated by HSF1, and the TLR4/MyD88/NF-κB signal pathway was involved in HSF1/HMGB1-mediated regulation of asthma. 31825792 2020
CUI: C0004096
Disease: Asthma
Asthma
0.100 Biomarker disease BEFREE Consequently, these findings highlight that CuE can ameliorate human bronchial epithelial cell insult and inflammation under LPS-simulated asthmatic conditions by blocking the HMGB1-TLR4-NF-κB signaling, thereby supporting its usefulness as a promising therapeutic agent against asthma. 31525576 2019
CUI: C0004096
Disease: Asthma
Asthma
0.100 Biomarker disease BEFREE In conclusion, our results suggest that HMGB1 and RAGE are involved in the pathogenesis of asthma. 31003767 2019
CUI: C0004096
Disease: Asthma
Asthma
0.100 AlteredExpression disease BEFREE A significantly elevation of HMGB1 protein expression and a reduction of miR-216a-5p expression were observed in children with asthma as well as in H₂O₂ stimulated 16HBE cells. 30502088 2019
CUI: C0004096
Disease: Asthma
Asthma
0.100 Biomarker disease BEFREE Sputum from subjects with asthma (n = 87) or COPD (n = 73) and ACO (n = 68) or from smokers (n = 62) and never-smokers (n = 62) was analyzed for high mobility group protein B1 (HMGB1), heat shock protein 70 (HSP70), LL-37, S100A8, and galectin-3 (Gal-3). 31848359 2019
CUI: C0004096
Disease: Asthma
Asthma
0.100 Biomarker disease BEFREE These results show TLR4 and HMGB1 both contribute to DINP-induced asthma, and that the inhibitions of TLR4 or HMGB1 offer potential means of treating asthma induced by phthalates like DINP. 31588340 2019
CUI: C0004096
Disease: Asthma
Asthma
0.100 Biomarker disease BEFREE Vitamin D reduces inflammatory response in asthmatic mice through HMGB1/TLR4/NF‑κB signaling pathway. 29257249 2018
CUI: C0004096
Disease: Asthma
Asthma
0.100 Biomarker disease BEFREE However, the relationship between the ATP/P2X7-NLRP3 axis and HMGB1 in DCs in asthma is still unclear. 29545090 2018
CUI: C0004096
Disease: Asthma
Asthma
0.100 Biomarker disease BEFREE In vivo, an OVA-induced asthma mouse model was set up and mice treated with anti-HMGB1 IgG. 29292841 2018
CUI: C0004096
Disease: Asthma
Asthma
0.100 Biomarker disease BEFREE Recent studies demonstrated that HMGB1 (High mobility group box 1 protein) regulates airway inflammation and the Th2, Th17 inflammatory response in asthma. 29567318 2018
CUI: C0004096
Disease: Asthma
Asthma
0.100 Biomarker disease BEFREE Taken together all results found here, we may suggest HMGB1 is an important therapeutic target for asthma, once orchestrates the redox signaling, inflammation, and remodeling that contribute to the disease development. 28391514 2017
CUI: C0004096
Disease: Asthma
Asthma
0.100 AlteredExpression disease BEFREE The area under the receiver operating characteristic curve, performed to define the diagnostic profile of sputum HMGB1 levels in identifying the children with asthma, was 0.713. 28441990 2017
CUI: C0004096
Disease: Asthma
Asthma
0.100 AlteredExpression disease BEFREE An inverse and strict correlation between sputum HMGB1 levels and pulmonary function indices also were observed in children with mild (FEV1%, r = -0.86544, P < .0001; FEF25%-75%, r = -0.53948, P < .05), moderate (FEV1%, r = -0.99548, P < .0001; FEF25%-75%, r = -0.48668, P < .05), and severe (FEV1%, r = -0.90191, P < .0001; FEF25%-75%, r = -0.66777, P < .05) asthma. 26250770 2015
CUI: C0004096
Disease: Asthma
Asthma
0.100 Biomarker disease BEFREE Increased abundance of HMGB1 is associated with several pathological disorders such as cancer, asthma and chronic obstructive pulmonary disease (COPD). 25726846 2015
CUI: C0004096
Disease: Asthma
Asthma
0.100 AlteredExpression disease BEFREE Sputum HMGB1 expressions were markedly higher in asthmatics than in normal controls, and were positively correlated with sputum eosinophilia and sputum TNF-α, IL-5 and IL-13 expressions. 22909167 2012